Immunoglobulin (Prophylaxis)
Pregnancy: Used in pregnancy — standard of care in RhD-negative women
Anti-D Immunoglobulin
Brand names: D-Gam, Rhophylac
Adult dose
Dose: Routine antenatal prophylaxis: 1500 units at 28 weeks (or 500 units at 28 and 34 weeks). Sensitising event: 250 units IM (≤20 weeks gestation); 500 units IM (>20 weeks). Postnatal: 500 units IM within 72h of delivery (if infant Rh-positive).
Route: IM injection (or slow IV for some products)
Frequency: As indicated by gestational age and sensitising events
Max: 1500 units per dose (antenatal); higher if large FMH
For RhD-negative women to prevent rhesus alloimmunisation. Kleihauer test after significant haemorrhage — if large FMH, additional anti-D may be needed. Anti-D given within 72h of sensitising event.
Paediatric dose
Route: N/A
Frequency: N/A
Max: Not applicable in paediatrics
Not applicable in paediatric patients
Dose adjustments
Renal
No dose adjustment required
Hepatic
No dose adjustment required
Clinical pearls
- 72-hour window: anti-D ideally within 72h of sensitising event — still beneficial up to 9 days but efficacy reduced
- Kleihauer-Betke test: performed after any significant antepartum or intrapartum haemorrhage to quantify FMH — determines if additional anti-D is needed (>4 mL FMH)
- Sensitising events requiring anti-D: amniocentesis, CVS, external cephalic version, abdominal trauma, antepartum haemorrhage, miscarriage (>12 weeks or surgical management at any stage)
- Check maternal blood group and antibody screen at booking and 28 weeks — if already sensitised, anti-D is futile
Contraindications
- RhD-positive women
- Previous sensitisation (anti-D antibodies already present)
- IgA deficiency with anti-IgA antibodies (IV route risk)
Side effects
- Injection site pain
- Fever and chills (rare)
- Anaphylaxis (very rare)
- Haemolysis (if given to RhD-positive person in error)
Interactions
- Live vaccines — delay for 3 months after anti-D immunoglobulin administration (may impair immune response to live vaccines)
Monitoring
- Maternal blood group confirmation
- Antibody screen (before administration)
- Kleihauer test after large haemorrhage
- Gestational age at time of sensitising event
Reference: BNFc; BNF; NICE NG25; BCSH Guidelines Anti-D Administration; RCOG Green-top 22. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Caprini Score for VTE Risk (2005) · VTE Risk
- Caprini VTE Risk Assessment · Venous Thromboembolism
- Revised Original International Autoimmune Hepatitis Score (IAIHG) · Autoimmune Liver Disease
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
- Khorana Score for VTE in Cancer · VTE Risk
- IMPROVE-DD VTE Risk Score · VTE Risk